The results of the clinical trial are expected by March 2021
The following publications are available on Open access:
- Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?
- Validation of a Lower Back “Wearable”-Based Sit-to-Stand and Stand-to-Sit Algorithm for Patients With Parkinson's Disease and Older Adults in a Home-Like Environment
- Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls
- Comparison of Internal Standard Approaches for SRM Analysis of Alpha-Synuclein in Cerebrospinal Fluid
- Poly‐GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD
- Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
- Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species
- Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay
- Iron as a therapeutic target for Parkinson's disease
- Bioavailable Trace Metals in Neurological Diseases
- Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
- Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
- Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement